We are live on ! Find out more
SBSB

Sullivan, Bruyette, Speros & Blaney Portfolio holdings

AUM $2.27B
1-Year Est. Return 50.71%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+50.71%
3 Year Est. Return
+46.71%
5 Year Est. Return
+87.02%
10 Year Est. Return
AUM
$1.1B
AUM Growth
+$56.8M
Cap. Flow
-$13M
Cap. Flow %
-1.18%
Top 10 Hldgs %
83.75%
Holding
177
New
10
Increased
69
Reduced
48
Closed
7

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.43M
2
AMZN icon
Amazon
AMZN
+$487K
3
NSC icon
Norfolk Southern
NSC
+$448K
4
WAB icon
Wabtec
WAB
+$419K
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$338K

Sector Composition

Rank Sector Weight
1 Technology 4.75%
2 Healthcare 2.66%
3 Financials 1.67%
4 Energy 1.27%
5 Consumer Staples 1.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
101
Automatic Data Processing
ADP
$105B
$440K 0.04%
2,923
+40
+1% +$5.66K
IJT icon
102
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.23B
$439K 0.04%
4,356
-138
-3% -$13.9K
SDY icon
103
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$439K 0.04%
4,487
-153
-3% -$14.8K
AUB icon
104
Atlantic Union Bankshares
AUB
$6.01B
$437K 0.04%
11,342
+2
+0% +$82
MA icon
105
Mastercard
MA
$504B
$437K 0.04%
1,963
-44
-2% -$9.18K
MPC icon
106
Marathon Petroleum
MPC
$91.3B
$431K 0.04%
5,395
APD icon
107
Air Products & Chemicals
APD
$65.3B
$414K 0.04%
2,480
+5
+0.2% +$814
ESRX
108
DELISTED
Express Scripts Holding Company
ESRX
$413K 0.04%
4,352
+122
+3% +$10.4K
GILD icon
109
Gilead Sciences
GILD
$162B
$412K 0.04%
5,333
-66
-1% -$4.99K
WAB icon
110
Wabtec
WAB
$49.2B
$408K 0.04%
+3,891
New +$419K
CVS icon
111
CVS Health
CVS
$134B
$406K 0.04%
5,163
+96
+2% +$6.86K
SAIC icon
112
Saic
SAIC
$4.87B
$406K 0.04%
5,042
-1,005
-17% -$85.4K
AET
113
DELISTED
Aetna Inc
AET
$398K 0.04%
1,961
-126
-6% -$24.6K
NOC icon
114
Northrop Grumman
NOC
$75.9B
$397K 0.04%
1,250
+4
+0.3% +$1.22K
CLX icon
115
Clorox
CLX
$11.6B
$394K 0.04%
2,622
AXP icon
116
American Express
AXP
$228B
$389K 0.04%
3,656
HRI icon
117
Herc Holdings
HRI
$4.94B
$384K 0.03%
7,500
CNI icon
118
Canadian National Railway
CNI
$77.2B
$377K 0.03%
4,200
C icon
119
Citigroup
C
$223B
$365K 0.03%
5,094
-441
-8% -$31.2K
TFC icon
120
Truist Financial
TFC
$63.6B
$362K 0.03%
7,462
GL icon
121
Globe Life
GL
$14.1B
$357K 0.03%
4,122
-60
-1% -$5.18K
BNY
122
Bank of New York Mellon
BNY
$106B
$356K 0.03%
6,987
IMO icon
123
Imperial Oil
IMO
$61.6B
$354K 0.03%
10,927
CL icon
124
Colgate-Palmolive
CL
$73B
$340K 0.03%
5,071
+3
+0.1% +$200
IXJ icon
125
iShares Global Healthcare ETF
IXJ
$4.06B
$339K 0.03%
5,387
-1,615
-23% -$97.6K

Similar funds

Sullivan, Bruyette, Speros & Blaney's Q3 2018 Portfolio in Review

As of Q3 2018, Sullivan, Bruyette, Speros & Blaney held 177 positions worth $1.1B, up 5.4% from $1.05B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Sullivan, Bruyette, Speros & Blaney's Q3 2018 filing shows 10 new, 69 increased, 48 reduced and 7 closed positions. Its largest new stake was Wabtec: 3,891 shares worth $408K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $8.88M.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Sullivan, Bruyette, Speros & Blaney's largest Q3 2018 buy was Wabtec: 3,891 shares worth $408K.
  • Sullivan, Bruyette, Speros & Blaney added most to Microsoft in Q3 2018, an estimated $4.43M increase.
  • Sullivan, Bruyette, Speros & Blaney's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $8.88M.
  • Sullivan, Bruyette, Speros & Blaney fully exited Wgl Holdings in Q3 2018, selling an estimated $2.11M.
  • Sullivan, Bruyette, Speros & Blaney's ten largest holdings make up 84% of its $1.1B portfolio in Q3 2018.
  • Sullivan, Bruyette, Speros & Blaney opened 10 new positions and closed 7 in Q3 2018.
  • Sullivan, Bruyette, Speros & Blaney's portfolio value rose 5.4% quarter-over-quarter to $1.1B.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q3 2018, filed 30 Oct 2018.